Home Page Potential Lawsuit FDA Issues Corrective Recalls over St. Jude Pacemakers Cyber Security
FDA Issues Corrective Recalls over St. Jude Pacemakers Cyber Security
Santa Clara, CA: The US Food and Drug Administration (FDA) has issued a recall specifically for corrective action, to reduce the risk of patient harm due to potential exploitation of cybersecurity vulnerabilities for certain Abbott (formerly St. Jude Medical) pacemakers.
The firmware update will be available beginning August 29, 2017. Pacemakers manufactured beginning August 28, 2017 will have this update pre-loaded in the device and will not need the update.
The FDA has reviewed information concerning potential cybersecurity vulnerabilities associated with St. Jude Medical's RF-enabled implantable cardiac pacemakers and has confirmed that these vulnerabilities, if exploited, could allow an unauthorized user (i.e. someone other than the patient's physician) to access a patient's device using commercially available equipment. This access could be used to modify programming commands to the implanted pacemaker, which could result in patient harm from rapid battery depletion or administration of inappropriate pacing.
Many medical devices, including St. Jude Medical's implantable cardiac pacemakers, contain configurable embedded computer systems that can be vulnerable to cybersecurity intrusions and exploits. As medical devices become increasingly interconnected via the Internet, hospital networks, other medical devices, and smartphones, there is an increased risk of exploitation of cybersecurity vulnerabilities, some of which could affect how a medical device operates.
Legal HelpIf you or a loved one has suffered similar damages or injuries, please fill in our form and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Please click here for a free evaluation of your FDA Issues Corrective Recalls over St. Jude Pacemakers Cyber Sec claim
Published on Aug-29-17
FDA ISSUES CORRECTIVE RECALLS OVER ST. JUDE PACEMAKERS CYBER SEC LEGAL ARTICLES AND INTERVIEWS
The Fix is In for St. Jude Defective Batteries, But Is it Enough?
November 9, 2017Washington, DC: The announcement last month of a new software tool capable of alerting patients with defective St. Jude cardiac defibrillators when a battery is in danger of failing prematurely may be too little, too late for patients who have suffered adverse events when defective defibrillator batteries failed too soon. Many have filed St. Jude ICD and CRT-D device lawsuits over the issue [READ MORE]
Criticism for Both St. Jude Medical and FDA over Defective St. Jude ICD Batteries
October 20, 2017Washington, DC: A troubling report that ran in The New York Times back in April shed a dark shadow on defective St. Jude cardiac defibrillators and the batteries that powered them. St Jude ICD and CRT-D device lawsuits have alleged further than the original manufacturer of the medical devices, St. Jude Medical, downplayed reports of device failure for years. And it’s not just St. Jude lawsuit plaintiffs making that allegation; so too, is the US Food and Drug Administration (FDA), according to The New York Times (04/13/17) [READ MORE]
Were Defective St. Jude Cardiac Defibrillators Implanted Even After Recall?
October 9, 2017Washington, DC: The complaint in the ASEA/AFSCME Local 52 Health Benefits Trust defective St Jude cardiac defibrillator lawsuit contains shocking new allegations. The fact-finding that follows may give patients the information they need to seek redress [READ MORE]
MORE FDA ISSUES CORRECTIVE RECALLS OVER ST. JUDE PACEMAKERS CYBER SEC LEGAL NEWS
READ MORE [ Defective Products Settlements and Legal News ]
READ MORE [ Drugs/Medical Settlements and Legal News ]
READ MORE [ Internet/Technology Settlements and Legal News ]
READ MORE [ Personal Injury Settlements and Legal News ]
Diana S. Yockey
I WISH They had done this when my GrandMother SUFFERED SO !!!!! THEY put her through HELL for 3 more years before she died !!!!!!!!!!!!! I HOPE THEY PAY DEARLY !!!!!!!!!!!
ADD YOUR COMMENT ON THIS ISSUE